The regulatory connection between miR-100 and FGFR3 has been described in osteosarcoma [53], bladder cancer [54], glioblastoma [55], lung cancer [56], prostate cancer [57] and pancreatic cancer [58], but has never been reported in BC. Here, FGFR3 is linked to prostate cancer.